Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues (NYSE:MED)
· seekingalpha.com
Medifast (MED) Q2 2026 earnings call recap: Trilivy brand shift, coach productivity trends, Catalyst cost cuts, and Q3/Q4 2026 outlook—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...